Centene Stock Surges as 2026 Profit Forecast Gets a Medical-Cost Boost
Centene Corp raised its 2026 profit outlook after first-quarter earnings topped estimates, citing improved medical cost control. Shares jumped over 6%. The company reported Q1 revenue of $49.94 billion and adjusted diluted EPS of $3.37. Centene lifted its 2026 EPS floor to above $3.40 and raised its full-year revenue forecast to as much as $191.5 billion.